Healthcare Financial News

how to drive. He said that no one had dreamed that the pharma company would gift them a car which surprised the employees. One of the employees who received the new car, Shilpa said, "I have completed eight years here...

₹1 lakh in December 2000 would have been ₹21 lakh today. From the latest intra high of 17,754.05, dated September 12, it went down by 7.25% on October 26, and on November 3, Nifty 50 closed at 17,000.95, which is 4.25% lower. A short-term break in the long-term growing market.

The death toll in the fire that broke out at a pharmaceutical company in Maharashtra’s Raigad district on Friday has risen to four, reported PTI, citing officials. Seven people are injured and a search operation is underway to trace seven missing individuals.

GST collections stood at ₹1.72 lakh crore for October 2023, a jump of 11% compared to the same month last year. UPI recorded an all-time high of 11.41 billion transactions amounting ₹17.16 trillion in October 2023, reporting an 8% jump in volume from the previous month.

Canada is required by law to release immigration targets for how many permanent residents it aims to welcome to the country by November 1 each year (there is an exception for election years). The latest release continues the trend of outlining the numbers of permanent residents projected over the next three years allocated according to 4 broad categories with sub-targets for each: economic, family, refugee and humanitarian. The overall target for 2024 and 2025 will remain as indicated in last year’s 3 year levels plan: 485,000, then 500,000. However, the target will not increase for 2026 but will remain flat at 500,000. Think you check all the immigration boxes? Find out It is important to note that these targets do not relate strictly to newcomers. The Immigration Minister noted that 35% of the next year’s permanent residents are already in Canada. Thus, while there is a housing crisis in Canada, 35% of 485,000 targeted for next year are already being housed. Also, the targets relate only to permanent residents and do not cover the 2.2 million people in Canada who are visiting, studying or working in temporary status. There are no caps on visitors, workers or students and Canada is on track to bring in 900,000 international students alone next year. While the Immigration Minister has been quite clear that newcomers are needed to address labour shortages, he also seems to be recognizing that public support for immigration has plummeted given many have been blaming newcomers for the housing shortage. This is unfortunate given governments have long failed to address housing issues before the more recent increases in temporary and permanent residents.

The nation’s employers slowed their hiring in October, adding a modest but still decent 150,000 jobs, a sign that the labor market may be cooling but remains resilient despite high interest rates that have made borrowing much costlier for companies and...

What's happening in the market? Why is the current volatility having such a big impact on my portfolio? How can I identify the stocks that pique my interest and have the potential for the best returns right now?

Zydus Lifesciences and Lupin on Friday announced signing of licensing and supply agreement to market Zydus' novel drug Saroglitazar Mg for the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steato Hepatitis (NASH) in India. Under the terms of this agreement, Lupin will have semi-exclusive rights to co-market the product in India under the brand name LINVAS. Zydus launched the drug under the brand names Lipaglyn and Bilypsa and will continue to market them. Lupin will pay Zydus upfront licensing fees and milestone payments based on the achievement of pre-defined milestones. With a once-daily, 4mg dose regimen, Saroglitazar Mg enables better compliance, reduces pill burden, and offers greater convenience for patients. «Saroglitazar Mg which is one of the critical treatments for patients with NAFLD and NASH has substantially improved the patients’ quality of life. We are pleased to join hands with Lupin to enable access to this novel drug and thereby expand the reach,» said Dr.

Micro Labs, a Bengaluru-based pharmaceutical company, is making its entry into the high-growth over-the-counter (OTC) segment by introducing a range of wellness products. As per a TOI report, the company initially plans to transfer a portion of its 'legacy' Dolo brand into the OTC segment. OTC medicines generally do not require a doctor's prescription and include products such as immunity-boosting vitamins, skin ointments, lozenges, and pain relief gels.

Delhi AQI News: Aam Aadmi Party (AAP) leader and Delhi Environment Minister Gopal Rai has shared an update on implementing the Odd-Even rule for plying of vehicles in national capital Delhi, as the city suffers a severely poor air quality ahead of winter. Minister Gopal Rai said that they are not deferring the Odd-Even rule as Delhi chokes from intense air pollution.

Mankind Pharma Ltd dipped more than 1% in the intraday trades on Friday. While some softness in the domestic growth visible reflected in the September quarter performance declared a few days back has been a cause of concern. Analysts expect the growth to improve moving forward.

Dabur India share price: Dabur share price rose over a per cent in early trade on NSE on Friday, November 3, extending its gains of the previous session after the FMCG company's Q2 earnings. Dabur share price rose 2.57 per cent to close at ₹530.40 in the previous session on Thursday after the company reported its September quarter earnings. On Friday, Dabur share price opened at ₹534.10 and soon rose 1.3 per cent to the level of ₹537.10 on the NSE.

“For the next Samvat, I think we should return back to a regime where there will be a preference for quality/cash cows which have underperformed,” says Shiv Sehgal, President and head,Nuvama Capital Markets. In an interview with ETMarkets, Sehgal said: “I think to spot gems in a falling market, one should follow a sound bottoms up framework of stock picking” Edited excerpts: We have seen more than 6% correction from the highs in both Sensex and Nifty. What is fueling the fall – is it the combination of the rise in US Yields and geopolitical concerns? The Nifty50 and Indian equities have been outliers amongst the global equity bourses. It is perhaps the only index in the world that has hit fresh highs in 2023.

Mint in the week gone by. The Centre’s tax collections finally got back on track in August and September, while private equity firm Blackstone Group Inc is making an entry into India's healthcare sector by acquiring controlling stakes in Care Hospitals and Kims Health. After facing a slow pace in the first four months of the fiscal year, the central government’s gross tax collections have started showing healthier trends since August.

Dabur India Ltd on Thursday reported a 3.3% year-on-year increase in September quarter profit to ₹507.04 crore. Revenue from operations grew 7.27% to ₹3,203.84 crore. India FMCG volumes grew 3% y-o-y during the quarter, the maker of Vatika shampoo and Dabur Red toothpaste said in a stock exchange filing.

Sarbananda Sonowal inaugurated the 50 bedded Ayurvedic hospital at Dudhnoi in the Goalpara district of Assam. The hospital — the second such hospital to be opened in Assam in less than a month after Majuli — is equipped with all the major facilities including a state-of-the-art laboratory, a Panchakarma centre, an infertility clinic, a yoga unit apart from the OPD and IPD services. The Union Minister, Sarbananda Sonowal said, “It gives me immense pleasure that people of Dudhnoi and its adjoining areas can now avail the wonders of India’s rich heritage of Ayurveda.

Q. I am a software engineer working at the second headquarters of a global MNC in Hyderabad, my wife is also a software engineer running a small app development start-up. We have been investing in the Indian stock market for the past 7 years. However, the market has been erratic for the past 1-2 years. We are now planning to diversify our mutual fund investment into foreign funds too. We are planning to invest in international index mutual funds tracking US indices launched by several Indian mutual fund houses. At present, we are confused between the S&P 500 and the Nasdaq 100. Can you please throw some light on the differences between the two indices and the pros and cons of investing in international mutual funds? 

Immigration Levels Plan 2024-2026, Marc Miller, Immigration Minister, cited it is ‘tailored to support economic growth while balancing with the pressures in areas like housing, healthcare and infrastructure.’ As per the plan, Canada will invite 485,000 new immigrants in 2024, and 500,000 in 2025 and 2026 each year. Canada is currently facing an aging population and labour shortages in key sectors and hence, it is seeking to spur growth with the help of new qualified professionals from countries like India. In 2022, India provided 118,095 new permanent residents to Canada, more than a quarter of the total 437,120 new permanent residents for 2022, Immigration, Refugees and Citizenship Canada (IRCC) said.

By Nell Mackenzie

HCL Tech founder Shiv Nadar retained his position of most generous Indian for the third year in a row on the EdelGive Hurun India Philanthropy List 2023 by giving away Rs 2042 crore, or Rs 5.6 crore a day. Wipro’s Azim Premji came next, with an annual donation of Rs 1,774 crore. Nadar’s donation, 76% higher than a year ago, came to more than the amount donated by the rest of the philanthropists in the top 10, barring Premji. Mukesh Ambani was third on the list, with donations amounting to Rs 376 crore, a fall of 8% from a year ago. Seven women made it to the list, with philanthropist Rohini Nilekani donating the most at Rs 170 crore. Indian philanthropists seem to be giving more than ever before – in the 2023 list, 119 philanthropists contributed Rs 8445 crore, a jump of close to 60% from a year ago, and a 200% surge from three years ago. Fourteen Indians donated over Rs 100 crore according to the 2023 list, from 2 in 2018 while the number of Indians who donated over Rs 50 crore doubled from 2019, at 24. “This is a record year for big philanthropy… Given India’s potential for wealth creation and assuming a continued commitment to philanthropy by billionaires, I anticipate these figures to double over the next five years,” Hurun India MD and chief researcher Anas Rahman Junaid said in a statement.

(Reuters) -Eli Lilly on Thursday cut its annual profit outlook on charges related to recent acquisitions, and beat quarterly sales estimates driven by strong demand for its new blockbuster diabetes drug, Mounjaro.